Dynavax Technologies | Resultat Før Skat

Pre Tax Profit Lave om Dato
AbbVie USD 5.99B 243M 2023-12
Adma Biologics USD 2.56M 9.35M 2023-09
Amgen USD 3.03B 153M 2023-12
Dynavax Technologies USD 996K 13.15M 2023-12
Gilead Sciences USD 2.59B 586M 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Roche Holding CHF 10.33B 1.48B 2023-06
Sarepta Therapeutics USD -33174000 18.59M 2023-09
TG Therapeutics USD -14026000 127.96M 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



Dynavax Technologies Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.